Innowise Scientific Services

Innowise Scientific Services Innowise Scientific Services (InnowiseSS) is a Knowledge process and professional services organisation

Innowise Scientific Services (InnowiseSS) is a Knowledge process and professional services organisation providing advisory and operational services to the life sciences industry, covering research to product commercialisation landscape. We work with biopharmaceutical and research organisation to provide evidence-based turnkey solutions and services related to cutting edge translational research and drug development. Our services encompass following domains: Scientific Consultancy; Regulatory Affairs; Clinical Research; Scientific/Medical Writing and Drug safety & risk management. We redefine the scientific approach and support the technology with innovation.

Biosimilar, cell therapy, cellular immunotherapy and biological products- understanding regulatory road map may be chall...
20/11/2016

Biosimilar, cell therapy, cellular immunotherapy and biological products- understanding regulatory road map may be challenging, leverage on our expert regulatory services.
visit us at www.innowisess.com
Innowise Scientific Services

Interesting article on cancer metastasis....
24/08/2016

Interesting article on cancer metastasis....

Nature Reviews Clinical Oncology: Distant metastasis remains a common cause of death in patients with solid tumours, even after treatment with surgery, radiotherapy and/or chemotherapy. Treatment itself can sometimes cause or promote metastasis by increasing the number of circulating tumour cells. The authors of this article discuss preclinical and clinical data concerning cancer treatments, circulating tumour cell mobilization and other factors that might promote metastasis. http://go.nature.com/2bM6vTB (£)

Amarantus Biosciences receives orphan drug designation in the US for pediatric burns, unfortunately India does not have ...
15/08/2016

Amarantus Biosciences receives orphan drug designation in the US for pediatric burns, unfortunately India does not have provision of orphan drug designation in the drug and cosmetics act, 1940 therefore similar technology developed in India has no takers. Make in India

Amarantus BioScience’s clinical study of Engineered Skin substitute “ESS or Permaderm™” for the treatment of severe life-threatening burns in children revealed promising and significant results with 100% survival rate.

09/04/2016

Sometimes a simple idea can lead to innovation, all you need is the will to take up the challenge to address a problem. At Innowise Scientific Services we encourage innovation to address issues related to health care by providing translational research services. visit www.innowisess.com for more information.

08/03/2016

The revamped version of our website is now live; check out www.innowisess.com

Address

Tower A, Building No-5, 18th Floor, DLF Cyber City, DLF Phase III
Gurugram
122002

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+91 124 663 7647

Alerts

Be the first to know and let us send you an email when Innowise Scientific Services posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Innowise Scientific Services:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram